Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol
Affiliation
Mel and Enid Zuckerman College of Public Health, The University of ArizonaHealth Sciences Library, The University of Arizona
Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, The University of Arizona
Issue Date
2023-12-10
Metadata
Show full item recordPublisher
BMJ Publishing GroupCitation
Mantina NM, Nakayima Miiro F, Smith J, et al. Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol. BMJ Open 2023;13:e076234. doi: 10.1136/bmjopen-2023-076234Journal
BMJ OpenRights
© Author(s) (or their employer(s)) 2023. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Introduction Human papillomavirus (HPV) is the causative agent of nearly all cervical cancers. Despite the proven safety and efficacy of HPV vaccines in preventing HPV-related cancers, the global vaccine coverage rate is estimated to only be 15%. HPV vaccine coverage rates are more actively tracked and reported for adolescents 17 years and younger but there is still a critical window of opportunity to intervene and promote HPV vaccination among young adults aged 18-26 years who are still eligible to be vaccinated. This protocol for a qualitative evidence synthesis aims to review perspectives of HPV vaccination among young adults (18-26 years) and identify facilitators and barriers that influence HPV vaccination uptake and decision-making. Methods and analysis Seven databases will be searched from 1 January 2006 to the date of final search. For inclusion, studies must report HPV vaccination perspectives of young adults aged 18-26 years and use qualitative study methods or analysis techniques. Studies will be screened in a two-stage process guided by the eligibility criteria. Final included studies will be evaluated for methodological strengths and limitations using the Critical Appraisal Skills Programme quality assessment tool for qualitative studies. After data extraction, framework analysis will be used to analyse the data applying the socioecological model. Finally, the Grading of Recommendations Assessment, Development and Evaluation - Confidence in the Evidence from Reviews of Qualitative research will be applied to evaluate the confidence in synthesised qualitative findings. The methodology of this review follows the Cochrane Handbook guidelines on qualitative evidence syntheses. Ethics and dissemination Formal ethical approval is not required for this study. Findings will be disseminated through peer-reviewed publications, conference presentations and professional networks. PROSPERO registration number CRD42023417052. © The Author(s) 2023.Note
Open access journalISSN
2044-6055PubMed ID
38072486Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1136/bmjopen-2023-076234
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © Author(s) (or their employer(s)) 2023. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license.
Related articles
- Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.
- Authors: Mrklas KJ, MacDonald S, Shea-Budgell MA, Bedingfield N, Ganshorn H, Glaze S, Bill L, Healy B, Healy C, Guichon J, Colquhoun A, Bell C, Richardson R, Henderson R, Kellner J, Barnabe C, Bednarczyk RA, Letendre A, Nelson GS
- Issue date: 2018 Mar 2
- Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
- Authors: Lim ASE, Lim RBT
- Issue date: 2019 Sep 24
- Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.
- Authors: Zheng L, Wu J, Zheng M
- Issue date: 2021 Dec 1
- HPV vaccination and Native Americans: protocol for a systematic review of factors associated with HPV vaccine uptake among American Indians and Alaska Natives in the USA.
- Authors: Gopalani SV, Sedani AE, Janitz AE, Clifton SC, Stoner J, Peck J, Comiford A, Salvatore AL, Campbell J
- Issue date: 2020 Sep 6
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
- Authors: Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N
- Issue date: 2019 Nov 22